Cash & equivalents increased 33.6%
Cash & equivalents changed +33.6% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +33.6% from the comparable as-filed period.
Net income changed +99.1% from the comparable as-filed period.
Operating income changed +101.7% from the comparable as-filed period.
Selling, general & administrative changed +15.3% from the comparable as-filed period.
Stock-based compensation changed +16.2% from the comparable as-filed period.
Research & development changed +7.6% from the comparable as-filed period.
Debt changed +0.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Inventory changed +1.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.